NCT00440232View on ClinicalTrials.gov

A Research Study To Evaluate If Frovatriptan Is Safe And Effective In Preventing Migraine Headache After Fasting

NACompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

September 30, 2009

Conditions
Migraine
Interventions
DRUG

Frovatriptan

Frovatriptan 5.0 mg orally one time at the start of the 20 hour fast

DRUG

Placebo

Inert tab identical in appearance to Frovatriptan

Trial Locations (1)

19107

Jefferson Headache Center, Philadelphia

All Listed Sponsors
lead

Thomas Jefferson University

OTHER

NCT00440232 - A Research Study To Evaluate If Frovatriptan Is Safe And Effective In Preventing Migraine Headache After Fasting | Biotech Hunter | Biotech Hunter